Hansen Medical, Inc. (NASDAQ:HNSN) To Showcase Innovations At SIR Annual Scientific Meeting

1003

Dallas, Texas 03/20/2014 (FINANCIALSTRENDS) –  Hansen Medical, Inc. (NASDAQ:HNSN), a provider of intravascular robotics, said the company will present its Magellan Robotic System and its new 6Fr Robotic Catheter at the Society of Interventional Radiology’s (SIR) Annual Scientific Meeting, to be held from March 23-27 at the San Diego Convention Center.

At Booth 800, the company is expected to showcase product demonstrations and new innovations, and also exhibit the Magellan Robotic System.

Hansen will also sponsor a symposium, where the company will “discuss the new Magellan 6Fr Robotic Catheter and its potential to expand the role of Intravascular Robotics to include peripheral vascular procedures in smaller vessels.”

Chris Lowe, Interim CEO of Hansen Medical, said, “With the recent FDA 510(k) clearance for our Magellan 6Fr Catheter, we will be expanding the clinical applications for Intravascular Robotics to include procedures in smaller diameter vessels, many of which are performed by Interventional Radiologists. We are excited for the opportunity to showcase our Magellan System and the new catheter in this forum.”

Recently, Hansen Medical, Inc. (NASDAQ:HNSN) saw some insider buying activity happening on March 11, 2014. In a filing with the U.S. SEC, the company reported that Hansen Medical director Michael Eagle bought 10,000 shares of the company’s stock on the open market.

The shares were bought at an average price of $2.29 per share, and the total value of the transaction was $22,900.00. Following the completion of the shares acquisition, the director Michael Eagle now directly owns 16,250 shares of Hansen Medical, Inc. (NASDAQ:HNSN)’s stock, valued at about $37,213.

The company last posted its quarterly earnings on February 20th. Hansen Medical reported $0.12 loss per share, beating the Thomson Reuters consensus estimate of $0.14 loss per share. The revenue for the quarter was $5.60 million versus consensus estimates’ of $5.90 million. Hansen Medical is expected to post $0.40 loss per share for the current fiscal year by the consensus.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.